Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18725086 | 0.88 | PTGER2 (0.89) | PTGER2PTGER4 | |
| SCHEMBL10316712 | 0.87 | PTGER2 (0.72) | PTGER2PTGER4 | |
| SCHEMBL10316859 | 0.86 | PTGER2 (0.80) | PTGER2PTGER4 | |
| SCHEMBL10316814 | 0.86 | PTGER2 (0.83) | PTGER2PTGER4 | |
| Hydrochloric Acid SCHEMBL534379 | 0.86 | PTGER2 (1.00) | PTGER2PTGER4 | |
| SCHEMBL533125 | 0.86 | PTGER2 (1.00) | PTGER2PTGER4 | |
| SCHEMBL12982328 | 0.86 | PTGER2 (1.00) | PTGER2 | |
| Hydrochloric Acid SCHEMBL12981114 | 0.86 | PTGER2 (1.00) | PTGER2 | |
| SCHEMBL10322376 | 0.85 | PTGER2 (0.75) | PTGER2PTGER4 | |
| Hydrochloric Acid SCHEMBL10316624 | 0.85 | PTGER2 (0.75) | PTGER2PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2520570-A1 | AMINOPYRIDINE COMPOUND | Ube Industries, Ltd. (JP) | 2012-11-07 | — | — | EP | claimed |
| US-20120259123-A1 | AMINOPYRIDINE COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2012-10-11 | — | — | US | claimed |
| EP-2520570-A1 | AMINOPYRIDINE COMPOUND | Ube Industries, Ltd. (JP) | 2012-11-07 | — | — | EP | disclosed |
| US-20120259123-A1 | AMINOPYRIDINE COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2012-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120259123-A1 | AMINOPYRIDINE COMPOUND | PTGIS, QDPR, PTGIR | PTGER2 59/4885PTGER4 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.